Navigation Links
San Antonio Drug Side Effects Lawyer at Herrera Law Firm Says Blood Clot Research Raises Questions About Yaz, Yasmin and Ocella
Date:12/16/2012

San Antonio, TX (PRWEB) December 16, 2012

Yaz, Yasmin and Ocella injury lawyers today said a study published in the Canadian Medical Association Journal on Dec. 3 raises some alarming concerns about the birth control blood clot risk.

According to a Dec. 3, 2012, report in the Reuters about the study, women who have a hormone disorder known as polycystic ovary syndrome (PCOS) and who use birth control pills have twice the risk of blood clots than do other women who take the Pill.

A 2011 study also published in the Canadian Medical Association Journal linked the birth control pills Yaz, Yasmin and Ocella, which contain drospirenone, to a higher risk of blood clots, according to an article about the study reported in the Globe and Mail of Toronto on Nov. 7, 2011. The blood clot risk is about 3 or 4 in 1,000 for women who take drospirenone-containing birth control pills compared with 1 in 1,000 for women who take birth control pills without drospirenone, according to the Globe and Mail.

“The various studies linking blood clots to certain birth control pills are alarming,” said San Antonio dangerous drug lawyer Jorge Herrera, of The Herrera Law Firm, Inc. “We urge anyone who has experienced adverse birth control side effects such as blood clots or stroke to speak to an attorney about their rights.”

In study published on Nov. 11, 2011, researchers followed contraceptive use among 329,995 Israeli women over a nearly seven-year period. The women who took the drospirenone-containing birth control pills had a higher risk of blood clots, deep vein thrombosis and pulmonary embolism than women who took other types of birth control, according to the study.
Birth control pills with drospirenone are relatively new contraceptives. Older birth control pills do not contain drospirenone.

In earlier research, the Food and Drug Administration found that Yaz is linked to a blood clot risk that is higher than older types of birth control, according to a CBS News report in 2011. According to CBS, the study examined women who used Yaz between 2001 and 2007.

About The Herrera Law Firm, Inc.
Founded in 1983, The Herrera Law Firm, Inc. has successfully represented thousands of individuals and families who have been dealt catastrophic blows due to personal injuries from oil field accidents, car accidents, tractor-trailer truck accidents, construction accidents, workplace injuries, dangerous drugs and defective medical device injuries. Its mission is to rectify the wrongs committed against its clients so that they can regain their dignity, rebuild their lives, and reclaim financial stability.

The firm’s principal office is located at 111 Soledad St., Suite 1900, San Antonio, TX 78205. The local phone number is 210-224-1054, or call toll-free at 1-800-455-1054. Visit http://www.herreralaw.com for more information.

Read the full story at http://www.prweb.com/releases/birth-control-lawsuit/lawyers/prweb10211401.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Young girls more likely to report side effects after HPV vaccine
2. Preteens More Likely to Report HPV Vaccine Side Effects
3. Breast cancer patients suffer treatment-related side effects long after completing care
4. Breast Cancer Treatment Side Effects May Last for Years
5. Baldness Drug May Cause Sexual Side Effects: FDA
6. Study examines adverse effects among different radiation therapies for prostate cancer
7. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
8. Moffitt researcher publishes book on nutritional management of cancer treatment effects
9. Researchers see BPA effects in monkey mammary glands
10. Many Primary Care Docs Dont Know Long-Term Effects of Chemo: Survey
11. Dartmouth researchers investigate the cognitive effects of athlete head impacts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: